Filing Details
- Accession Number:
- 0001209191-20-055054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 16:26:41
- Reporting Period:
- 2020-10-14
- Accepted Time:
- 2020-10-16 16:26:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204788 | M David Stack | C/O Pacira Biosciences, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054 | Ceo And Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-14 | 30,000 | $10.81 | 203,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-14 | 30,000 | $55.53 | 173,377 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-10-15 | 30,000 | $10.81 | 203,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-15 | 30,000 | $55.00 | 173,377 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-10-16 | 30,000 | $10.81 | 203,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-16 | 30,000 | $55.56 | 173,377 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-14 | 30,000 | $0.00 | 30,000 | $10.81 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-15 | 30,000 | $0.00 | 30,000 | $10.81 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-10-16 | 30,000 | $0.00 | 30,000 | $10.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 233,670 | 2022-06-05 | No | 4 | M | Direct | |
| 203,670 | 2022-06-05 | No | 4 | M | Direct | |
| 173,670 | 2022-06-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,596 | Indirect | By Stack Schroon Mohawk FLP |
| Common Stock | 1,208 | Indirect | By LCK Investment LLC |
Footnotes
- The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
- The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.
- Reflects the transfer of stock options to purchase 243,129 shares of common stock previously held indirectly by the reporting person through LCK Investment LLC to the reporting person directly.
Billionaire Hedge Funds
